[Familial Mediterranean fever, clinical and laboratory findings]

P Vinceneux1, J Pouchot

  • 1Service de médicine interne 5, Hôpital Louis Mourier, AP-HP, Colombes. philippe.vinceneux@lmr.ap-hop-paris.fr

Presse Medicale (Paris, France : 1983)
|September 6, 2005
PubMed

Insights

Familial Mediterranean fever (FMF) is an autoinflammatory disease primarily affecting those of Mediterranean descent. Caused by mutations in the MEFV gene, FMF involves recurrent inflammatory flares with fever and various organ system symptoms.

Area of Science:

  • Genetics and Immunology
  • Autoinflammatory Diseases

Context:

  • Familial Mediterranean fever (FMF) is a well-known recurrent hereditary autoinflammatory disease.
  • It primarily impacts individuals of Mediterranean origin, particularly Sephardic Jews.

Purpose:

  • To describe the genetic basis, clinical manifestations, and diagnostic features of Familial Mediterranean fever.
  • To highlight the importance of recognizing FMF symptoms for timely diagnosis and management.

Summary:

  • FMF is caused by mutations in the MEFV gene, located on chromosome 16, with autosomal recessive inheritance and incomplete penetrance.
  • The disease involves recurrent inflammatory episodes, typically starting before age 20, characterized by fever and symptoms affecting the abdomen, joints, pleura, or skin.
  • Clinical presentation includes acute flares that are usually reversible, but persistent findings like organomegaly may occur. Laboratory results show nonspecific inflammation with moderate hyperleukocytosis during flares.

Impact:

  • Understanding FMF's genetic and clinical profile aids in differentiating it from other inflammatory conditions.
  • Early diagnosis and management can prevent long-term complications and improve patient outcomes.
  • This information is crucial for clinicians managing patients with recurrent unexplained fevers and inflammatory symptoms.

Related Concept Videos

Rapid Identification of Pathogens01:25

Rapid Identification of Pathogens

MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Yellow Fever01:18

Yellow Fever

Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...